首页> 外文期刊>Tumour biology : >Microlocalization of CD68(+) tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients
【24h】

Microlocalization of CD68(+) tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients

机译:CD68(+)肿瘤相关巨噬细胞在肿瘤基质中的微定位与口腔鳞状细胞癌患者的不良临床预后相关

获取原文
获取原文并翻译 | 示例
           

摘要

CD68 has been widely used as a pan-macrophage marker for tumor-associated macrophages (TAM) which always involve in carcinogenesis. But the correlations between CD68(+) TAMs and prognosis of patients show to be inconsistent, which might due to lack of specific markers of TAMs. We here found that the microlocalization of CD68(+) TAMs also played a unique role in prognosis of patients with oral squamous cell carcinoma (OSCC). CD68(+) TAMs were identified in paraffin-embedded OSCC specimens (n=91) by using immunohistochemistry. The number of CD68(+) TAMs was remarkably increased from adjacent none-neoplasia tissues (NT) to tumor nest (TN), but tumor stroma (TS) was infiltrated with highest frequency of CD68(+) TAMs (P<0.0001). Unexpectedly, more CD68(+) TAMs in TS, but not NT or TN, were associated with high tumor grade (P=0.033), lymph node metastasis (P=0.034), and shorter 10-year overall survival time, disease free survival. Considering TAMs was derived from monocytes in peripheral blood, we assessed the relationship between leukocytes in peripheral blood and CD68(+) TAMs in OSCC and found that more CD68(+) TAMs in TS were accompanied with decreased monocytes and lymphocytes in peripheral blood (P<0.05). Although Cox regression analysis revealed that CD68(+) TAMs in TS were not an independent prognostic factor for OSCC patients, we raised a possibility that the microlocalization of CD68(+) TAMs was an indispensable factor for the advance of OSCC.
机译:CD68已被广泛用作肿瘤相关巨噬细胞(TAM)的泛巨噬细胞标记,而巨噬细胞总是参与致癌作用。但是,CD68(+)TAM与患者预后之间的相关性显示不一致,这可能是由于TAM缺乏特异性标志物所致。我们在这里发现CD68(+)TAM的微定位在口腔鳞状细胞癌(OSCC)患者的预后中也起着独特的作用。使用免疫组织化学方法在石蜡包埋的OSCC标本中鉴定出CD68(+)TAM(n = 91)。 CD68(+)TAM的数量从相邻的非肿瘤组织(NT)到肿瘤巢(TN)显着增加,但肿瘤基质(TS)的CD68(+)TAM出现频率最高(P <0.0001)。出乎意料的是,TS中更多的CD68(+)TAM,而不是NT或TN与高肿瘤等级(P = 0.033),淋巴结转移(P = 0.034)和较短的10年总生存时间,无病生存相关。考虑到TAM来源于外周血中的单核细胞,我们评估了外周血中白细胞与OSCC中CD68(+)TAM之间的关系,发现TS中更多的CD68(+)TAM伴随着外周血中单核细胞和淋巴细胞的减少(P <0.05)。尽管Cox回归分析显示TS中的CD68(+)TAM不是OSCC患者的独立预后因素,但我们提出CD68(+)TAM的微定位是OSCC进步不可或缺的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号